Actinium Pharmaceuticals, Inc. (ATNM) Operating Lease, Right-of-Use Asset USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Actinium Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2019 to 2024.
  • Actinium Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $2.14 M, a 15.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $2.14 M -$404 K -15.9% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $2.29 M -$52 K -2.22% Dec 31, 2023 10-Q 2024-04-26
Q3 2023 $2.44 M -$18 K -0.73% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $2.58 M -$48 K -1.83% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.54 M +$2.39 M +1574% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $2.34 M +$2.1 M +871% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $2.45 M +$2.13 M +648% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.63 M +$2.22 M +537% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $152 K -$344 K -69.4% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $241 K -$338 K -58.4% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $328 K -$331 K -50.2% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $413 K -$325 K -44% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $496 K -$319 K -39.1% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $579 K -$228 K -28.3% Dec 31, 2020 10-K 2022-03-25
Q3 2020 $659 K -$304 K -31.6% Sep 30, 2020 10-Q 2020-10-23
Q2 2020 $738 K -$298 K -28.8% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $815 K -$292 K -26.4% Mar 31, 2020 10-Q 2020-06-30
Q4 2019 $807 K Dec 31, 2019 10-K 2021-03-31
Q3 2019 $963 K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.04 M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $1.11 M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.